Core Viewpoint - Weiao Co., Ltd. is developing a pressurized oxygen chamber technology aimed at improving human adaptability in high-altitude environments, which can alleviate symptoms of altitude sickness [1] Company Summary - Weiao Co., Ltd. has indicated that its oxygen chamber technology operates by simulating lower altitude conditions through pressurization, thereby increasing the oxygen partial pressure within the chamber [1] - The technology is particularly suitable for use in high-altitude regions, enhancing the body's ability to adapt to such environments [1] Industry Summary - The pressurized oxygen therapy market is likely to see growth due to increasing awareness of altitude sickness and the need for effective solutions in high-altitude areas [1] - The application of this technology could benefit various sectors, including tourism, sports, and healthcare, where high-altitude exposure is common [1]

格隆汇7月31日丨威奥股份(605001.SH)在互动平台表示，雅下工程位于高原地区，增压氧舱是一种通过 技术手段，在密闭空间内模拟较低海拔环境，其核心原理在于通过加压的方式，提高舱内的氧气分压， 使得舱内空气的氧气含量与较低海拔地区的水平相当，适合在高原地区使用。通过增压氧疗，有助于提 高机体在高原地区的适应能力，减轻高原反应症状。 ...

Group 1 - The core viewpoint of the article highlights the comprehensive channel strategy of O2arK oxygen chamber, which includes "online precision reach + offline scenario penetration + vertical field cooperation" to meet the full chain demand from individual consumers to B-end institutions [1] - The increasing aging population in China is leading to a rise in the incidence of chronic diseases among the elderly, resulting in a growing demand for health improvement products [1] - The O2arK oxygen chamber is suitable for various scenarios such as home, leisure, office, and commercial use, catering to different levels of consumer needs [1] Group 2 - The company has signed strategic cooperation agreements with overseas clients, continuously expanding its overseas market presence [1] - Currently, the company has successfully established over 10 locations for the O2arK oxygen chamber in Tibet, covering high-altitude areas such as Daocheng Yading, Barkhor Street, Yamdrok Lake, Namtso Lake, and Mount Kailash [1]

格隆汇7月31日丨威奥股份(605001.SH)在互动平台表示，雅下工程位于高原地区，增压氧舱是一种通过 技术手段，在密闭空间内模拟较低海拔环境，其核心原理在于通过加压的方式，提高舱内的氧气分压， 使得舱内空气的氧气含量与较低海拔地区的水平相当，适合在高原地区使用。公司正在积极与相关方接 洽，争取为雅下工程提供保障服务。 ...

威奥股份7月31日在互动平台表示，雅下工程位于高原地区，增压氧舱是一种通过技术手段，在密闭空 间内模拟较低海拔环境，其核心原理在于通过加压的方式，提高舱内的氧气分压，使得舱内空气的氧气 含量与较低海拔地区的水平相当，适合在高原地区使用。公司正在积极与相关方接洽，争取为雅下工程 提供保障服务。 ...

Core Viewpoint - The company emphasizes the importance of enhancing quality over stock price manipulation in its market value management strategy, aligning with regulatory guidelines and focusing on long-term investment value [2]. Group 1: Stock Performance - As of July 25, 2025, the stock price of Weiao Co., Ltd. (605001) closed at 7.72 yuan, reflecting an increase of 0.52% with a turnover rate of 2.68% and a trading volume of 105,300 shares, resulting in a transaction value of 81.1471 million yuan [1]. Group 2: Investor Relations - The company acknowledges the importance of market value management as a means to enhance company quality rather than manipulate stock prices, committing to high-quality development to improve long-term investment value [2]. - The company confirmed its capability to manufacture products based on PEEK thermoplastic composite materials and reinforced laminated materials [2]. - The subsidiary, Weiao Automotive Technology (Tangshan) Co., Ltd., possesses the equipment to produce carbon fiber products but currently lacks the ability to produce carbon fiber raw materials [2]. Group 3: Trading Information - On July 25, the net inflow of main funds into Weiao Co., Ltd. was 3.092 million yuan, accounting for 3.81% of the total transaction value, while retail investors experienced a net outflow of 3.1617 million yuan, representing 3.9% of the total transaction value [3].

Group 1 - The high-pressure oxygen chamber concept increased by 1.55%, ranking second among concept sectors, with three stocks rising, including a 20% limit up for Tiebian Heavy Industry [1] - The leading gainers in the high-pressure oxygen chamber sector were International Medicine and Yinkang Life, which rose by 0.93% and 0.20% respectively [1] - The sector saw a net inflow of 0.50 billion yuan from main funds, with Tiebian Heavy Industry receiving the highest net inflow of 1.03 billion yuan [2][3] Group 2 - The main fund inflow ratios for Tiebian Heavy Industry, International Medicine, and Jinling Pharmaceutical were 29.36%, 10.10%, and 5.54% respectively [3] - The trading performance of stocks in the high-pressure oxygen chamber sector showed varied results, with Tiebian Heavy Industry leading in both price increase and fund inflow [3][4] - Stocks such as Weiao and Innovation Medical experienced significant declines, with net outflows of -3214.35 million yuan and -4427.60 million yuan respectively [4]

Group 1 - The high-pressure oxygen chamber concept increased by 2.63%, ranking 10th among concept sectors, with five stocks rising, including a 20% limit-up for Tiedao Heavy Industry [1] - Notable gainers in the high-pressure oxygen chamber sector include Innovation Medical and Samsung Medical, which rose by 3.29% and 0.96% respectively [1] - The sector experienced a net inflow of 170 million yuan from main funds, with Tiedao Heavy Industry receiving the highest net inflow of 120 million yuan [2] Group 2 - The top stocks by net inflow ratio in the high-pressure oxygen chamber sector are Tiedao Heavy Industry at 39.19%, International Medical at 4.88%, and Samsung Medical at 4.16% [3] - The trading volume and turnover rates for key stocks in the sector indicate significant investor interest, with Tiedao Heavy Industry showing a turnover rate of 0.97% [3] - Decliners in the sector included Dahu Co., which fell by 0.55%, and Aoyang Health, which decreased by 0.50% [4]

Group 1 - The high-pressure oxygen chamber concept increased by 3.78%, ranking 8th among concept sectors, with 8 stocks rising, including a 20% limit up for Tiebian Heavy Industry [1] - The leading stocks in the high-pressure oxygen chamber sector included Weiao Co., International Medicine, and Dahu Co., which rose by 3.80%, 3.24%, and 2.44% respectively [1] - The high-pressure oxygen chamber sector saw a net inflow of 152 million yuan from main funds, with 6 stocks receiving net inflows, and 5 stocks exceeding 10 million yuan in net inflow [2] Group 2 - The top net inflow stock was Tiebian Heavy Industry, with a net inflow of 60.89 million yuan, followed by International Medicine, Samsung Medical, and Aoyang Health with net inflows of 57.53 million yuan, 42.20 million yuan, and 22.89 million yuan respectively [2] - In terms of net inflow ratios, Aoyang Health, Tiebian Heavy Industry, and International Medicine had the highest ratios at 15.77%, 14.47%, and 11.68% respectively [3] - The trading performance of stocks in the high-pressure oxygen chamber sector showed significant activity, with Tiebian Heavy Industry achieving a daily increase of 19.90% and a turnover rate of 1.60% [3]

Group 1 - The high-pressure oxygen chamber concept declined by 2.26%, ranking among the top declines in concept sectors, with companies like Aoyang Health, International Medicine, and Weiao Co., Ltd. experiencing significant drops [1] - The main funds in the high-pressure oxygen chamber concept saw a net outflow of 363 million yuan, with seven stocks experiencing net outflows, led by Innovation Medical with a net outflow of 308 million yuan [2] - Other companies with notable net outflows include Aoyang Health, Dahu Co., Ltd., and Yinkang Life, with net outflows of 27.01 million yuan, 8.53 million yuan, and 6.79 million yuan respectively [2] Group 2 - The top gainers in concept sectors included the military equipment restructuring concept, which rose by 3.51%, and PCB concept, which increased by 3.29% [2] - The high-pressure oxygen chamber concept was among the sectors with the largest declines, alongside glyphosate and rare earth permanent magnets, which fell by 2.82% and 2.57% respectively [2] - The trading volume for the high-pressure oxygen chamber concept stocks showed varying turnover rates, with Innovation Medical at 36.76% and Aoyang Health at 17.53% [2]